Radiologic Assessment of Response to Therapy: Comparison of RECIST Versions 1.1 and 1.0
Authors:
- Hamid ChalianHCHamid Chalian
- Hüseyin Gürkan TöreHTHüseyin Gürkan Töre
- Jeanne M. HorowitzJHJeanne M. Horowitz
- Riad SalemRSRiad Salem
- Frank H. MillerFMFrank H. Miller
- Vahid YaghmaiVYVahid Yaghmai
- 1 November 2011
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 31 (7) , 2093-2105
Abstract
Improvements in radiologic imaging technology and therapeutic options available for management of tumors have necessitated the revision of guidelines for the imaging-based assessment of tumor response to therapy. The purpose of this article is to familiarize radiologists with the modifications to the Response Evaluation Criteria in Solid Tumors (RECIST) that have been incorporated in the latest version of the guidelines, RECIST 1.1. The most important differences between this version and the previous one, RECIST 1.0, include reductions in the maximum number of lesions per patient and per organ that may be targeted for measurement, augmentation of the criteria defining progressive disease, additional guidelines for reporting findings of lesions that are too small to measure and for measuring lesions that appear to have fragmented or coalesced at follow-up imaging, new criteria for characterizing lymphadenopathy, new criteria for selecting bone lesions and cystic lesions as targets for measurement, and the inclusion of findings at positron emission tomography among the indicators of disease response.Keywords
This publication has 18 references indexed in Scilit:
- Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapyCancer Treatment Reviews, 2009
- Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?European Radiology, 2009
- A simulation study to evaluate the impact of the number of lesions measured on response assessmentEuropean Journal of Cancer, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Evaluation of lymph nodes with RECIST 1.1European Journal of Cancer, 2009
- Individual patient data analysis to assess modifications to the RECIST criteriaEuropean Journal of Cancer, 2009
- Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinomaCancer, 2003
- A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Reporting results of cancer treatmentCancer, 1981